Ligand Pharma (LGND) PT Raised to $93 at Cantor Fitzgerald Jun 19, 2015 06:35AM
Ligand to Participate in Four Upcoming Investor Conferences Jun 17, 2015 05:00PM
Cantor Fitzgerald Reiterate Hold Following Ligand Pharma's (LGND) Strong Q1 May 13, 2015 07:23AM
Cantor Fitzgerald Negative on Ligand Pharma (LGND) Reaction Post-Earnings Feb 12, 2014 09:13AM
Notable Analyst Rating Changes 11/15: (MDRX) (BLL) (LGND) Upgraded; (BBRY) (GOGO) (K) Downgraded Nov 15, 2013 10:59AM


Nov 15, 2013 07:21AM Cantor Fitzgerald Upgrades Ligand Pharma (LGND) to Hold
Oct 16, 2013 06:22AM Ligand Pharma (LGND) Enters $24M At-The-Market Offering with MLV, Brinson Patrick
Aug 2, 2013 08:15AM Cantor Cuts Ligand Pharma (LGND) to Sell, Says 'Take Money Off Table'
Jul 1, 2013 11:59AM Ligand Pharma (LGND) Swings Higher, but Upside Could Be Limited
Jan 4, 2013 08:02AM Cantor Fitzgerald Downgrades Ligand Pharma (LGND) to Hold
Jul 23, 2012 08:41AM Cantor Fitzgerald Maintains a 'Buy' on Ligand Pharma (LGND); Key Partnered Drug is Approved
Jun 7, 2012 05:48PM Cantor Fitzgerald Starts Ligand Pharma (LGND) at Buy; Fundamentally Undervalued; Building Momentum In 2012
Jan 22, 2009 10:05AM Notable Analyst Rating Changes 1/22: BBY, AAP, ERIC, M Upgraded; DOX, MRVL, K, WYE Downgraded